UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 45

Sortiert nach

Imatinib Mesylate in Advanced Dermatofibrosarcoma Protuberans: Pooled Analysis of Two Phase II Clinical Trials

Journal of clinical oncology, 2010-04, Vol.28 (10), p.1772-1779

2010

Link zum Volltext

Verfügbarkeit prüfen

Emergency surgery in the era of molecular treatment of solid tumours

The lancet oncology, 2009-02, Vol.10 (2), p.157-163

2009

Link zum Volltext

Verfügbarkeit prüfen

The Megavoltage Radiation Therapy in Treatment of Patients With Advanced or Difficult Giant Cell Tumors of Bone

International journal of radiation oncology, biology, physics, 2010-10, Vol.78 (2), p.494-498

2010

Link zum Volltext

Verfügbarkeit prüfen

Rectal gastrointestinal stromal tumors associated with a novel germline KIT mutation

International journal of cancer, 2008-05, Vol.122 (9), p.2160-2164

2008

Link zum Volltext

Verfügbarkeit prüfen

Risk criteria and prognostic factors for predicting recurrences after resection of primary gastrointestinal stromal tumor

Annals of surgical oncology, 2007-07, Vol.14 (7), p.2018-2027

2007

Link zum Volltext

Verfügbarkeit prüfen

Functional features of gene expression profiles differentiating gastrointestinal stromal tumours according to KIT mutations and expression

BMC cancer, 2009-11, Vol.9 (1), p.413-413

2009

Link zum Volltext

Verfügbarkeit prüfen

Post-surgery adjuvant therapy with intermediate doses of interferon alfa 2b versus observation in patients with stage IIb/III melanoma (EORTC 18952): randomised controlled trial

The Lancet (British edition), 2005-10, Vol.366 (9492), p.1189-1196

2005

Link zum Volltext

Verfügbarkeit prüfen

Increased cancer risk of heterozygotes with NBS1 germline mutations in poland

International journal of cancer, 2004-08, Vol.111 (1), p.67-71

2004

Link zum Volltext

Verfügbarkeit prüfen

Surgical treatment of patients with initially inoperable and/or metastatic gastrointestinal stromal tumors (GIST) during therapy with imatinib mesylate

Journal of surgical oncology, 2006-03, Vol.93 (4), p.304-311

2006

Link zum Volltext

Verfügbarkeit prüfen

Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma

Annals of surgical oncology, 2006-12, Vol.13 (12), p.1655-1663

2006

Link zum Volltext

Verfügbarkeit prüfen

Surgery combined with intraoperative brachytherapy in the treatment of retroperitoneal sarcomas

Annals of surgical oncology, 2006-02, Vol.13 (2), p.245-252

2006

Link zum Volltext

Verfügbarkeit prüfen

Presence of homozygous KIT exon 11 mutations is strongly associated with malignant clinical behavior in gastrointestinal stromal tumors

Laboratory investigation, 2007-10, Vol.87 (10), p.1029-1041

2007

Link zum Volltext

Verfügbarkeit prüfen

Predictive factors for long-term effects of imatinib therapy in patients with inoperable/metastatic CD117(+) gastrointestinal stromal tumors (GISTs)

Journal of cancer research and clinical oncology, 2007-09, Vol.133 (9), p.589-597

2007

Link zum Volltext

Verfügbarkeit prüfen

Gastrointestinal Stromal Tumors: Key to Diagnosis and Choice of Therapy

Molecular diagnosis & therapy, 2008-01, Vol.12 (3), p.131-143

2008

Link zum Volltext

Verfügbarkeit prüfen

Melanoma without a Detectable Primary Site with Metastases to Lymph Nodes

Dermatologic surgery, 2010-06, Vol.36 (6), p.868-876

2010

Link zum Volltext

Verfügbarkeit prüfen

Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: Correlations with local tumor extent and prognosis

Journal of surgical oncology, 2003-11, Vol.84 (3), p.151-159

2003

Link zum Volltext

Verfügbarkeit prüfen

Cytokine serum levels in soft tissue sarcoma patients: Correlations with clinico‐pathological features and prognosis

International journal of cancer, 2002-08, Vol.100 (4), p.463-471

2002

Link zum Volltext

Verfügbarkeit prüfen

Different factors are responsible for predicting relapses after primary tumors resection and for imatinib treatment outcomes in gastrointestinal stromal tumors

Medical science monitor, 2007-11, Vol.13 (11), p.CR515-CR522

2007

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Value of Multiple Reverse Transcription-PCR Tyrosinase Testing for Circulating Neoplastic Cells in Malignant Melanoma

Clinical chemistry (Baltimore, Md.), 2003-09, Vol.49 (9), p.1450-1457

2003

Link zum Volltext

Verfügbarkeit prüfen

Cutaneous melanoma with nodal metastases in elderly people

International Journal of Dermatology, 2010-08, Vol.49 (8), p.907-913

2010

Link zum Volltext

Verfügbarkeit prüfen

Detection of melanoma cells in the lymphatic drainage after lymph node dissection in melanoma patients by using two-marker reverse transcriptase-polymerase chain reaction assay

Annals of surgical oncology, 2004-11, Vol.11 (11), p.988-997

2004

Link zum Volltext

Verfügbarkeit prüfen

Surgery combined with brachytherapy in patients with retroperitoneal sarcomas

Journal of contemporary brachytherapy, 2010-03, Vol.2 (1), p.14-23

2010

Link zum Volltext

Verfügbarkeit prüfen

Multimarker Reverse Transcriptase-Polymerase Chain Reaction Assay in Lymphatic Drainage and Sentinel Node Tumor Burden

Annals of surgical oncology, 2010-12, Vol.17 (12), p.3314-3323

2010

Link zum Volltext

Verfügbarkeit prüfen

Sentinel lymph node biopsy in melanoma patients with clinically negative regional lymph nodes--one institution's experience

Melanoma research, 2003-02, Vol.13 (1), p.35-43

2003

Link zum Volltext

Verfügbarkeit prüfen

Molecular staging by multimarker reverse transcriptase-polymerase chain reaction assay of lymphatic drainage and blood from melanoma patients after lymph node dissection

Melanoma research, 2008-08, Vol.18 (4), p.246-252

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 45

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(42)

Publikationsform

Artikel
(45)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Imatinib Mesylate in Advanced Dermatofibrosarcoma Protuberans: Pooled Analysis of Two Phase II Clinical Trials

Emergency surgery in the era of molecular treatment of solid tumours

The Megavoltage Radiation Therapy in Treatment of Patients With Advanced or Difficult Giant Cell Tumors of Bone

Rectal gastrointestinal stromal tumors associated with a novel germline KIT mutation

Risk criteria and prognostic factors for predicting recurrences after resection of primary gastrointestinal stromal tumor

Functional features of gene expression profiles differentiating gastrointestinal stromal tumours according to KIT mutations and expression

Post-surgery adjuvant therapy with intermediate doses of interferon alfa 2b versus observation in patients with stage IIb/III melanoma (EORTC 18952): randomised controlled trial

Increased cancer risk of heterozygotes with NBS1 germline mutations in poland

Surgical treatment of patients with initially inoperable and/or metastatic gastrointestinal stromal tumors (GIST) during therapy with imatinib mesylate

Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma

Surgery combined with intraoperative brachytherapy in the treatment of retroperitoneal sarcomas

Presence of homozygous KIT exon 11 mutations is strongly associated with malignant clinical behavior in gastrointestinal stromal tumors

Predictive factors for long-term effects of imatinib therapy in patients with inoperable/metastatic CD117(+) gastrointestinal stromal tumors (GISTs)

Gastrointestinal Stromal Tumors: Key to Diagnosis and Choice of Therapy

Melanoma without a Detectable Primary Site with Metastases to Lymph Nodes

Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: Correlations with local tumor extent and prognosis

Cytokine serum levels in soft tissue sarcoma patients: Correlations with clinico‐pathological features and prognosis

Different factors are responsible for predicting relapses after primary tumors resection and for imatinib treatment outcomes in gastrointestinal stromal tumors

Prognostic Value of Multiple Reverse Transcription-PCR Tyrosinase Testing for Circulating Neoplastic Cells in Malignant Melanoma

Cutaneous melanoma with nodal metastases in elderly people

Detection of melanoma cells in the lymphatic drainage after lymph node dissection in melanoma patients by using two-marker reverse transcriptase-polymerase chain reaction assay

Surgery combined with brachytherapy in patients with retroperitoneal sarcomas

Multimarker Reverse Transcriptase-Polymerase Chain Reaction Assay in Lymphatic Drainage and Sentinel Node Tumor Burden

Sentinel lymph node biopsy in melanoma patients with clinically negative regional lymph nodes--one institution's experience

Molecular staging by multimarker reverse transcriptase-polymerase chain reaction assay of lymphatic drainage and blood from melanoma patients after lymph node dissection

Suchergebnisse filtern